Not applicableStudy completedNCT04600804What this trial is testingThe Role of 18F-FDG-PET for Staging and PrognosticationWho this might be right forMantle Cell Lymphoma Fondazione Italiana Linfomi - ETS 200
Testing effectiveness (Phase 2)Study completedNCT00596804What this trial is testingSafety Study of Different Doses of hA20 (Veltuzumab) in CD20+ Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkin's LymphomaLymphoma, DiffuseLymphoma, Diffuse, Mixed Lymphocytic-Histiocytic Gilead Sciences 39
Early research (Phase 1)Study completedNCT00005021What this trial is testingCombination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or LymphomaWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific Fox Chase Cancer Center 17
Testing effectiveness (Phase 2)UnknownNCT00003163What this trial is testingPeripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell CancersWho this might be right forLymphomaMultiple Myeloma and Plasma Cell Neoplasm Medical College of Wisconsin 10
Not applicableWithdrawnNCT01769911What this trial is testingGenetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAIDS-related Diffuse Large Cell LymphomaAIDS-related Diffuse Mixed Cell Lymphoma+42 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00041132What this trial is testingS0213 Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell LymphomaWho this might be right forLymphoma SWOG Cancer Research Network 56
Testing effectiveness (Phase 2)Study completedNCT01437709What this trial is testingOfatumumab With or Without Bendamustine for Patients With Mantle Cell Lymphoma Ineligible for Autologous Stem Cell TransplantWho this might be right forMantle Cell Lymphoma Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT07261163What this trial is testingObinutuzumab, Zanubrutinib, and Lenalidomide in First-line Treatment of Mantle Cell LymphomaWho this might be right forMantle Cell Lymphoma Institute of Hematology & Blood Diseases Hospital, China 37
Testing effectiveness (Phase 2)Study completedNCT00018954What this trial is testingChemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma National Institutes of Health Clinical Center (CC)
Not applicableEnded earlyNCT00062231What this trial is testingMoxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With CancerWho this might be right forChronic Myeloproliferative DisordersFever, Sweats, and Hot FlashesInfection+8 more European Organisation for Research and Treatment of Cancer - EORTC 351
Testing effectiveness (Phase 2)Active Not RecruitingNCT03153202What this trial is testingStudy to Evaluate the Safety and Preliminary Efficacy of Ibrutinib and Pembrolizumab in Patients With Chronic Lymphocytic Leukemia (CLL) or Mantle Cell Lymphoma (MCL)Who this might be right forChronic Lymphocytic LeukemiaMantle Cell Lymphoma Joshua Brody 23
Large-scale testing (Phase 3)UnknownNCT00016887What this trial is testingChemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell LymphomaWho this might be right forLymphoma German Low Grade Lymphoma Study Group
Testing effectiveness (Phase 2)Study completedNCT01263899What this trial is testingA Safety and Efficacy Study of SB1518 for the Treatment of Advanced Lymphoid MalignanciesWho this might be right forHodgkin LymphomaMantle Cell LymphomaIndolent Lymphoma S*BIO 28
Testing effectiveness (Phase 2)Study completedNCT00023764What this trial is testingBortezomib in Treating Patients With Lymphoproliferative DisordersWho this might be right forRecurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Grade 3 Follicular Lymphoma+1 more National Cancer Institute (NCI) 103
Testing effectiveness (Phase 2)WithdrawnNCT00005998What this trial is testingPeripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's DiseaseWho this might be right forLymphoma Masonic Cancer Center, University of Minnesota
Early research (Phase 1)Ended earlyNCT01728207What this trial is testingPhase I Dose Escalation Study of IMMU-114 in Relapsed or Refractory NHL and CLLWho this might be right forNon-hodgkin's LymphomaFollicular LymphomaMantle Cell Lymphoma+3 more Gilead Sciences 30
Testing effectiveness (Phase 2)Ended earlyNCT01685606What this trial is testingStudy of Infusion of Blood Cells (Lymphocytes) to Stimulate the Immune System to Fight Leukemia/LymphomaWho this might be right forMantle Cell LymphomaDiffuse Large Cell LymphomaBurkitts Lymphoma+2 more Brown University 6
Early research (Phase 1)Study completedNCT00446342What this trial is testingStudy of Intravenously Administered SNS-032 in Patients With Advanced B-lymphoid MalignanciesWho this might be right forB-lymphoid MalignanciesChronic Lymphocytic LeukemiaMantle Cell Lymphoma+1 more Sunesis Pharmaceuticals 21
Testing effectiveness (Phase 2)UnknownNCT02819583What this trial is testingCAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and LymphomaWho this might be right forAcute Lymphocytic LeukemiaChronic Lymphocytic LeukemiaFollicular Lymphoma+3 more PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT04205409What this trial is testingNivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic MalignanciesWho this might be right forRecurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell LymphomaRecurrent Follicular Lymphoma+15 more University of Washington 20